APA 6th Edition

Milovanovič Jarh, D., Grošelj, M. & Barbič-Žagar, B. (2017). Evidence-based therapy with Krka’s rosuvastatin in primary and secondary prevention of cardiovascular disease.. Cardiologia Croatica, 12 (4), 161-165. https://doi.org/10.15836/ccar2017.161

---

MLA 8th Edition

Milovanovič Jarh, Darja, et al. "Evidence-based therapy with Krka’s rosuvastatin in primary and secondary prevention of cardiovascular disease.." Cardiologia Croatica, vol. 12, no. 4, 2017, pp. 161-165. https://doi.org/10.15836/ccar2017.161. Accessed 5 Jan. 2025.

---

Chicago 17th Edition

Milovanovič Jarh, Darja, Mateja Grošelj and Breda Barbič-Žagar. "Evidence-based therapy with Krka’s rosuvastatin in primary and secondary prevention of cardiovascular disease.." Cardiologia Croatica 12, no. 4 (2017): 161-165. https://doi.org/10.15836/ccar2017.161

---

Harvard

Milovanovič Jarh, D., Grošelj, M., and Barbič-Žagar, B. (2017). 'Evidence-based therapy with Krka’s rosuvastatin in primary and secondary prevention of cardiovascular disease.', Cardiologia Croatica, 12(4), pp. 161-165. https://doi.org/10.15836/ccar2017.161

---

Vancouver

Milovanovič Jarh D, Grošelj M, Barbič-Žagar B. Evidence-based therapy with Krka’s rosuvastatin in primary and secondary prevention of cardiovascular disease.. Cardiologia Croatica [Internet]. 2017 [cited 2025 January 05];12(4):161-165. https://doi.org/10.15836/ccar2017.161

---

IEEE

D. Milovanovič Jarh, M. Grošelj and B. Barbič-Žagar, "Evidence-based therapy with Krka’s rosuvastatin in primary and secondary prevention of cardiovascular disease.", Cardiologia Croatica, vol.12, no. 4, pp. 161-165, 2017. [Online]. https://doi.org/10.15836/ccar2017.161

APA 6th Edition

Milovanovič Jarh, D., Grošelj, M. & Barbič-Žagar, B. (2017). Evidence-based therapy with Krka’s rosuvastatin in primary and secondary prevention of cardiovascular disease.. Cardiologia Croatica, 12 (4), 161-165. https://doi.org/10.15836/ccar2017.161

---

MLA 8th Edition

Milovanovič Jarh, Darja, et al. "Evidence-based therapy with Krka’s rosuvastatin in primary and secondary prevention of cardiovascular disease.." Cardiologia Croatica, vol. 12, no. 4, 2017, pp. 161-165. https://doi.org/10.15836/ccar2017.161. Accessed 5 Jan. 2025.

---

Chicago 17th Edition

Milovanovič Jarh, Darja, Mateja Grošelj and Breda Barbič-Žagar. "Evidence-based therapy with Krka’s rosuvastatin in primary and secondary prevention of cardiovascular disease.." Cardiologia Croatica 12, no. 4 (2017): 161-165. https://doi.org/10.15836/ccar2017.161

---

Harvard

Milovanovič Jarh, D., Grošelj, M., and Barbič-Žagar, B. (2017). 'Evidence-based therapy with Krka’s rosuvastatin in primary and secondary prevention of cardiovascular disease.', Cardiologia Croatica, 12(4), pp. 161-165. https://doi.org/10.15836/ccar2017.161

---

Vancouver

Milovanovič Jarh D, Grošelj M, Barbič-Žagar B. Evidence-based therapy with Krka’s rosuvastatin in primary and secondary prevention of cardiovascular disease.. Cardiologia Croatica [Internet]. 2017 [cited 2025 January 05];12(4):161-165. https://doi.org/10.15836/ccar2017.161

---

IEEE

D. Milovanovič Jarh, M. Grošelj and B. Barbič-Žagar, "Evidence-based therapy with Krka’s rosuvastatin in primary and secondary prevention of cardiovascular disease.", Cardiologia Croatica, vol.12, no. 4, pp. 161-165, 2017. [Online]. https://doi.org/10.15836/ccar2017.161